Thaker SK, Silverstein J, Konecny GE, Bardia A, et al. Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer. Curr Opin Obstet Gynecol 2026;38:48-56.
PMID: 41461040